C.-M. Tsai

Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low <scp>FODMAP</scp> diet in children with the irritable bowel syndrome

Bruno P. Chumpitazi, Julia Cope, Emily B. Hollister et al. · Alimentary Pharmacology & Therapeutics · 2015 · 431 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17

MDR1 Gene Expression in Lung Cancer

Shih-Wei Lai, Lori J. Goldstein, M M Gottesman et al. · JNCI Journal of the National Cancer Institute · 1989 · 184 citations

Medicine, Molecular Biology, Oncology +9

Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.

R P Perng, Y M Chen, Jacqueline Ming-Liu et al. · Journal of Clinical Oncology · 1997 · 147 citations

Medicine, Oncology, Pharmacology +16

A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)

Hiroshige Yoshioka, K. Azuma, Nobuyuki Yamamoto et al. · Annals of Oncology · 2015 · 117 citations · Full text

Medicine, Oncology, Pharmacology +16

Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines

C.-M. Tsai, Karen Chang, Li‐Hwa Wu et al. · Lung Cancer · 1996 · 104 citations

Medicine, Cell Biology, Oncology +13